Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2025Statistics in Biopharmaceutical ResearchOpen Access

On the two-step hybrid design for augmenting randomized trials using real-world data

View Full Paper
Ask AI
Bookmark
Share

Authors

JXJiapeng XuInnovative Research (United States)RERuben P. A. van EijkUtrecht UniversityAEAlicia M. EllisUCB Pharma (Belgium)

Discussion

Loading...

Member takes

Overview

Hybrid clinical trials improve statistical power using real-world data, suggesting better efficiency for rare diseases.

Key Points

  • Type I error control was improved using a two-step hybrid design, ensuring more accurate statistical results.
  • Methods proposed estimate variance and adjust critical values to manage type I error across tests.
  • These approaches were evaluated under various clinical trial conditions, highlighting advantages over traditional methods.
  • Increasing statistical power while respecting exchangeability, our methods mitigate common pitfalls in hybrid trial designs.

Cite This Study

Xu et al. (2025) studied this question.

synapsesocial.com/papers/68af53ffad7bf08b1eada906https://doi.org/10.1080/19466315.2025.2547855
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Power priors and type I error control: constrained borrowing of external control data2025
  2. 2Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study2025
  3. 3Control arm augmentation and hierarchical modeling in time-to-event trials: advantages and pitfalls2024
  4. 4A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling2024 · 3 citations
  5. 5Addressing Non‐Exchangeability in Hybrid Control Studies: A Variable Selection Approach2025